Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Cai, Cheng
CASINOs, NCT06204094: Node-sparing Radiotherapy Combined with Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer	Recruiting	2	37	RoW	node-sparing short-course radiotherapy, Sintilimab, IBI308, Capecitabine, Oxaliplatin, TME surgery, total mesorectal excision, watch and wait, WW	Jinhua Central Hospital	Locally Advanced Rectal Cancer	09/27	09/28